cannabis indica

Canabinoide Sintético (não especificado)

termo de indexação original: Synthetic Cannabinoid (unspecified)

Como esta categoria funciona

Categoria do acervo, não um composto. Reúne os estudos que tratam de canabinoides sintéticos sem nomear a molécula — comum em pesquisa epidemiológica, em relatos de intoxicação em que a substância não foi identificada e em revisões sobre novas substâncias psicoativas.

É uma limitação real da literatura, não apenas da classificação: em muitos casos de emergência médica o produto consumido nunca chega a ser analisado, e o artigo registra apenas "canabinoide sintético".

Quando a série é identificável, os estudos ficam nas páginas específicas: JWH, AM, WIN, HU, CP, SR e outras.

No acervo

O acervo do Cannabis Indica reúne 384 estudos científicos que tocam o composto Canabinoide Sintético (não especificado), publicados entre 1981 e 2024. Pela leitura automatizada, 216 (56%) foram classificados como favoráveis, 58 (15%) como inconclusivos e 110 (29%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (196 estudos), seguido de estudo em animais (83). As condições mais associadas são Intoxicação por Cannabis Sintética, Efeitos Adversos da Cannabis e Dor.

Estudos indexados
384
Período coberto
1981–2024
Favoráveis
216 · 56%
Inconclusivos
58 · 15%
Desfavoráveis
110 · 29%
Termo original
Synthetic Cannabinoid (unspecified)

O acervo em números

Tipo de estudo

Metanálise196
Estudo em Animais83
Ensaio Clínico Duplo-Cego38
Estudo Laboratorial33
Ensaio Clínico20
Metanálise Clínica14

Direção do resultado

Favorável216
Inconclusivo58
Desfavorável110

Por década

1980s3
1990s3
2000s48
2010s188
2020s142

384 estudos

Filtrar e buscar no acervo →

Esta página mostra 303 dos 384 estudos indexados sobre o tema, dos mais recentes aos mais antigos. Abra o acervo com este filtro para percorrer todos, ou baixe a lista completa em JSON e CSV.

  1. 2024

    Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs

    FavorávelMetanáliseAnsiedadeAnandamida (AEA)Endocanabinoide (não especificado)+4
  2. 2024

    Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial

  3. 2024

    Psychosexual dysfunction in male patients with cannabis dependence and synthetic cannabinoid dependence

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisLibido+1
  4. 2024

    Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile

    InconclusivoMetanáliseObesidadeTentativa de Suicídio
  5. 2023

    A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods

  6. 2023

    Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats

    FavorávelEstudo em AnimaisDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  7. 2023

    Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3

  8. 2023

    Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — CrônicaEsclerose Múltipla+3
  9. 2023

    Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

  10. 2023

    Cocaine-Induced Raynaud's Phenomenon: A Case Report

    DesfavorávelMetanáliseDependência QuímicaEfeitos Adversos da CannabisAnsiedade+11
  11. 2023

    Delta-8-THC association with psychosis: A case report with literature review

    DesfavorávelMetanáliseInflamaçãoDisfunção CognitivaPsicoseDelta-8-THC+6
  12. 2023

    Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease

    FavorávelMetanáliseDorAnsiedadeDor — CrônicaCBD Farmacêutico+4
  13. 2023

    Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  14. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  15. 2023

    Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus

    FavorávelMetanáliseZumbidoEndocanabinoide (não especificado)
  16. 2023

    Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device

  17. 2023

    Involvement of cannabinoid receptors and neuroinflammation in early sepsis: Implications for posttraumatic stress disorder

  18. 2023

    Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest

  19. 2023

    Monitoring Perfusion Index in Patients Presenting to the Emergency Department Due to Drug Use

  20. 2023

    Persistent Coagulopathy After Synthetic Cannabinoid Use

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  21. 2023

    Quantitative Analysis of Three Synthetic Cannabinoids MDMB-4en-PINACA, ADB-BUTINACA, and ADB-4en-PINACA by Thermal-Assisted Carbon Fiber Ionization Mass Spectrometry

  22. 2023

    Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  23. 2023

    Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+4
  24. 2023

    The endogenous cannabinoid system modulates male sexual behavior expression

  25. 2023

    Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study

    FavorávelEnsaio Clínico Duplo-CegoCâncerDoenças Cardiovasculares (DCV)Hipertensão ArterialCBD Farmacêutico
  26. 2023

    Turning down the spice: tackling the problems of synthetic cannabinoids

  27. 2022

    A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

  28. 2022

    A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse

  29. 2022

    Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services

  30. 2022

    Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review

  31. 2022

    Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors

  32. 2022

    Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoAnsiedadeAnandamida (AEA)
  33. 2022

    Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind placebo-controlled trial

    InconclusivoEnsaio Clínico Duplo-CegoDorAnsiedadeDepressão+1
  34. 2022

    Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice

  35. 2022

    Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis

    FavorávelEstudo em AnimaisDII — Doença Inflamatória IntestinalDII — Doença de Crohn
  36. 2022

    Cannabinoid therapeutics in orofacial pain management: a systematic review

  37. 2022

    Cannabinoids as anticancer drugs: current status of preclinical research

  38. 2022

    Cannabinoids in rheumatology: Friend, foe or a bystander?

  39. 2022

    Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

  40. 2022

    Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis

    InconclusivoMetanálise ClínicaCâncerAnsiedadeDepressãoTHC FarmacêuticoTHC:CBD Farmacêutico+5
  41. 2022

    Cannabinoids: Therapeutic Use in Clinical Practice

  42. 2022

    Cannabis and orofacial pain: a systematic review

    FavorávelMetanáliseDorInflamaçãoDor — Crônica+2
  43. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  44. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+28
  45. 2022

    Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists

  46. 2022

    Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model

  47. 2022

    Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving

  48. 2022

    Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids

  49. 2022

    Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA—parent compounds and metabolite identification in blood, urine and cerebrospinal fluid

    DesfavorávelMetanáliseEfeitos Adversos da CannabisCanabinoides Sintéticos 5F-x
  50. 2022

    Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice

  51. 2022

    GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Hipertensão Arterial
  52. 2022

    Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis

    DesfavorávelMetanáliseDependência QuímicaCâncerDependência — Cannabis+17
  53. 2022

    In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists

    InconclusivoEstudo em AnimaisEfeitos Adversos da CannabisCanabinoides Sintéticos 5F-x
  54. 2022

    Inhibition of anandamide hydrolysis does not rescue respiratory abnormalities observed in an animal model of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de ParkinsonAnandamida (AEA)
  55. 2022

    Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

  56. 2022

    N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials

    InconclusivoMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+6
  57. 2022

    Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders

    FavorávelMetanáliseDorInflamaçãoEpilepsiaCanabidiol Anormal (Abn-CBD)+7
  58. 2022

    NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches

  59. 2022

    Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity

    FavorávelEstudo em AnimaisCistiteEndocanabinoide (não especificado)
  60. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  61. 2022

    Potential Implications of Rimonabant on Age-Related Oxidative Stress and Inflammation

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo
  62. 2022

    Role of cannabis in inflammatory bowel diseases

  63. 2022

    Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice

  64. 2022

    Synaptic changes induced by cannabinoid drugs and cannabis use disorder

  65. 2022

    Synthetic cannabinoids and ST elevation myocardial infarction

  66. 2022

    Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?

    FavorávelMetanáliseTEPTEndocanabinoide (não especificado)
  67. 2022

    The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study

  68. 2022

    The endocannabinoid system and drug-associated contextual memories

  69. 2022

    The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

    FavorávelMetanáliseAnsiedadeEndocanabinoide (não especificado)
  70. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

    FavorávelMetanáliseCâncerInflamaçãoAnsiedadeTHC FarmacêuticoCanabigerol (CBG)+26
  71. 2022

    The role of the cannabinoid system in fear memory and extinction in male and female mice

    InconclusivoEstudo em AnimaisTEPTAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  72. 2022

    What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?

  73. 2022

    Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

  74. 2021

    (m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice

    FavorávelEstudo em AnimaisDoença de Alzheimer
  75. 2021

    [Droghe d'abuso e rene] Drugs of Abuse and the Kidney

  76. 2021

    A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options

    DesfavorávelMetanáliseDorCâncerEfeitos Adversos da CannabisTHC Farmacêutico+6
  77. 2021

    Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22

    DesfavorávelEstudo em AnimaisIntoxicação por Cannabis SintéticaCanabinoides Sintéticos AM-x
  78. 2021

    Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice

    FavorávelEstudo em AnimaisEpilepsia
  79. 2021

    AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - An in vitro study

    FavorávelEstudo em AnimaisFibroseFibrose — CutâneaCanabinoides Sintéticos AM-x
  80. 2021

    An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesions

    InconclusivoEnsaio ClínicoHidrolase de Amidas de Ácidos Graxos (FAAH)
  81. 2021

    Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+3
  82. 2021

    Behavioral and pharmacological effects of cannabidiol (CBD) and the CBD analogue KLS-13019 in mouse models of pain and reinforcement

    FavorávelEstudo em AnimaisDorDor — Polineuropatia Induzida por Medicamentos
  83. 2021

    Cannabinoid Receptor 2 Agonism is Capable of Preventing Lipopolysaccharide Induced Decreases of Cochlear Microcirculation - A Potential Approach for Inner Ear Pathologies

    FavorávelEstudo em AnimaisInflamaçãoOtite MédiaCanabinoides Sintéticos JWH-x
  84. 2021

    Cannabinoid Signaling in Auditory Function and Development

    FavorávelMetanáliseZumbidoPerda AuditivaEndocanabinoide (não especificado)
  85. 2021

    Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective

  86. 2021

    Cannabinoids for the treatment of dementia

  87. 2021

    Cannabinoids in the landscape of cancer

    FavorávelMetanáliseCâncer
  88. 2021

    Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29)

    FavorávelEstudo LaboratorialCâncerCâncer — Cólon
  89. 2021

    Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review

  90. 2021

    CB 1 allosteric modulators and their therapeutic potential in CNS disorders

    FavorávelMetanálise
  91. 2021

    CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development

    FavorávelEstudo em AnimaisArtriteArtrite — OsteoartriteCanabinoides Sintéticos JWH-x
  92. 2021

    Chemical Emissions From Heated Vitamin E Acetate—Insights to Respiratory Risks From Electronic Cigarette Liquid Oil Diluents Used in the Aerosolization of Δ9-THC-Containing Products

    DesfavorávelEstudo LaboratorialEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  93. 2021

    Effects of a Novel GPR55 Antagonist on the Arachidonic Acid Cascade in LPS-Activated Primary Microglial Cells

    FavorávelEstudo LaboratorialInflamaçãoDepressãoDoença de Alzheimer
  94. 2021

    Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors

  95. 2021

    From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis

    FavorávelEstudo em AnimaisEsclerose Sistêmica
  96. 2021

    Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study

    InconclusivoEstudo LaboratorialDoenças PriônicasCanabinoides Sintéticos AM-x
  97. 2021

    Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

  98. 2021

    Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum

    FavorávelMetanáliseInflamaçãoEsclerose SistêmicaLúpus
  99. 2021

    Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

  100. 2021

    New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature

  101. 2021

    Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain

    FavorávelEstudo em AnimaisDorInflamaçãoDII — Doença Inflamatória Intestinal+2
  102. 2021

    Novel Δ8‐Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals

    DesfavorávelEstudo LaboratorialIntoxicação por Cannabis SintéticaDelta-8-THC
  103. 2021

    Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents

    FavorávelEstudo em AnimaisDII — Doença Inflamatória Intestinal
  104. 2021

    Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  105. 2021

    Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis

  106. 2021

    Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

  107. 2021

    Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS

    InconclusivoEstudo LaboratorialTHC FarmacêuticoCanabigerol (CBG)+2
  108. 2021

    Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?

  109. 2021

    Synthetic Cannabinoid-Related Deaths in England, 2012-2019

  110. 2021

    Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

  111. 2021

    Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  112. 2021

    Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

  113. 2021

    The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors

    FavorávelEstudo em AnimaisDorDor — Polineuropatia Induzida por Medicamentos
  114. 2021

    The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

  115. 2021

    The role of endocannabinoids in pregnancy

    InconclusivoMetanáliseGestaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  116. 2021

    Therapeutic and Cosmetic Uses of Cannabis: Cannabinoids for Acne Treatment and Skin -Rejuvenation

    FavorávelMetanáliseAcneEndocanabinoide (não especificado)
  117. 2021

    Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland

    FavorávelMetanáliseDorEpilepsiaNáusea e Vômito+1
  118. 2020

    AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema

    InconclusivoMetanáliseIntoxicação por Cannabis Sintética
  119. 2020

    Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain: A Systematic Review

    DesfavorávelMetanálise ClínicaDorTHC FarmacêuticoTHC:CBD Farmacêutico
  120. 2020

    Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB 1 R gene expression and reduces dyskinesias in a rat model of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de Parkinson
  121. 2020

    Brodifacoum-Laced Synthetic Marijuana Toxicity: A Fight Against Time

  122. 2020

    Cannabinoids CB2 Receptors, One New Promising Drug Target for Chronic and Degenerative Pain Conditions in Equine Veterinary Patients

    FavorávelMetanáliseAplicações Veterinárias
  123. 2020

    Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation

    InconclusivoEstudo em AnimaisCâncerCâncer — Escamoso de Cabeça e Pescoço
  124. 2020

    Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship

    DesfavorávelMetanáliseDisfunção Cognitiva
  125. 2020

    Characteristics and circumstances of synthetic cannabinoid-related death

    InconclusivoMetanáliseIntoxicação por Cannabis Sintética
  126. 2020

    Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83

    FavorávelEstudo LaboratorialCâncerCâncer — Cólon
  127. 2020

    Dual inhibition of cannabinoid CB 1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease

    FavorávelEstudo em AnimaisEstresse OxidativoObesidadeDoença Renal Crônica
  128. 2020

    Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

  129. 2020

    Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis

    FavorávelEstudo em AnimaisEsclerose Múltipla
  130. 2020

    Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia

  131. 2020

    Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)DiabetesSíndrome Metabólica+3
  132. 2020

    Stimulation of Brain Cannabinoid CB 1 Receptors Can Ameliorate Hypertension in Spontaneously Hypertensive Rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão Arterial
  133. 2020

    Synthetic cannabinoid receptor agonists-induced recurrent seizure in elderly patient

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  134. 2020

    Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia

  135. 2020

    Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study

    DesfavorávelEnsaio ClínicoEpilepsia
  136. 2020

    Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer's Disease Lymphoblast Alterations

    FavorávelMetanáliseDisfunção CognitivaDoença de AlzheimerDemência
  137. 2020

    The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects—A Randomized Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnorexia (perda de apetite)THC Farmacêutico+4
  138. 2020

    The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study

    FavorávelEnsaio Clínico Duplo-CegoDependência — CannabisAnsiedadePsicose+6
  139. 2020

    The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy

  140. 2020

    The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis

    FavorávelEstudo em AnimaisEsclerose Múltipla
  141. 2020

    The other side of the leaf: Seizures associated with synthetic cannabinoid use

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  142. 2020

    The peripheral CB 1 receptor antagonist JD5037 attenuates liver fibrosis via a CB 1 receptor/β-arrestin1/Akt pathway

    FavorávelEstudo em AnimaisFibroseFibrose — Hepática (Cirrose)
  143. 2019

    A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  144. 2019

    Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication

    DesfavorávelMetanáliseIntoxicação por Cannabis SintéticaDoenças da Retina
  145. 2019

    Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

    FavorávelMetanáliseInflamaçãoDoença de Parkinson
  146. 2019

    Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

    FavorávelEstudo em AnimaisInflamaçãoEsclerose MúltiplaDoenças Priônicas
  147. 2019

    Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis

    FavorávelEstudo em AnimaisInflamaçãoEsclerose Sistêmica
  148. 2019

    Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

  149. 2019

    Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?

  150. 2019

    Cannabinoids and Dementia: A Review of Clinical and Preclinical Data

  151. 2019

    CB1 positive allosteric modulation attenuates Δ9-THC withdrawal and NSAID-induced gastric inflammation.

    FavorávelEstudo em AnimaisDependência — Cannabis
  152. 2019

    Chronic Marijuana and Synthetic Cannabinoid-Induced Toxic Myocarditis and End-Stage Cardiomyopathy: Management With Mechanical Circulatory Support as a Bridge-to-Transplantation

  153. 2019

    Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — CannabisAnsiedade+8
  154. 2019

    Consequences of Perinatal Cannabis Exposure

    DesfavorávelEstudo em AnimaisGestação
  155. 2019

    Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment

  156. 2019

    Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption

  157. 2019

    Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisSíndrome do Intestino Irritável+2
  158. 2019

    Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.

    FavorávelEstudo em AnimaisAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  159. 2019

    Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC–MS and LC–MS-MS analysis

  160. 2019

    Medical cannabis and cannabinoids in rheumatology: where are we now?

  161. 2019

    Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — CannabisAnsiedade+6
  162. 2019

    Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis

    FavorávelEstudo LaboratorialUveíte
  163. 2019

    Substance Abuse Poisoning Reported to the Poisons Information Centre Erfurt from 2002 to 2016

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  164. 2019

    Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?

  165. 2019

    Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2

    InconclusivoEstudo LaboratorialGestaçãoCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x+1
  166. 2019

    Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures

    FavorávelEstudo em AnimaisEpilepsia
  167. 2019

    The endocannabinoid system and stroke: A focused review

    FavorávelMetanáliseAVC
  168. 2019

    The GPR55 Antagonist CID16020046 Protects Against ox-LDL-induced Inflammation in Human Aortic Endothelial Cells (HAECs)

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Aterosclerose
  169. 2019

    The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond

  170. 2019

    The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population

    DesfavorávelMetanálisePsicoseIntoxicação por Cannabis Sintética
  171. 2019

    Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats

    FavorávelMetanáliseInflamaçãoEpilepsiaAplicações Veterinárias+1
  172. 2019

    VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB2 receptor‐dependent pathways

    FavorávelEstudo em AnimaisInflamaçãoFibroseEsclerose Sistêmica+1
  173. 2018

    A new cause of ischaemic priapism: Synthetic cannabinoids.

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  174. 2018

    A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms

  175. 2018

    Acute myocardial infarction triggered by use of synthetic cannabis.

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  176. 2018

    Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA

  177. 2018

    Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  178. 2018

    Antinociceptive effects of JWH015 in female and male rats

  179. 2018

    Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review

  180. 2018

    Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.

  181. 2018

    Cannabinoids for the treatment of rheumatic diseases - where do we stand?

  182. 2018

    Cannabinoids in dermatology: a scoping review.

  183. 2018

    Cannabis and psychosis: what do we know and what should we do?

    DesfavorávelMetanálisePsicose
  184. 2018

    Cardiovascular Complications of Marijuana and Related Substances: A Review

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)
  185. 2018

    Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  186. 2018

    Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats

    InconclusivoEstudo em AnimaisAVC2-Araquidonoilglicerol (2-AG)
  187. 2018

    Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.

    FavorávelEstudo em AnimaisAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  188. 2018

    EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis

    FavorávelEstudo em AnimaisInflamaçãoFibroseEsclerose Sistêmica+1
  189. 2018

    Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.

    FavorávelEstudo em AnimaisEsclerose Múltipla
  190. 2018

    Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma.

  191. 2018

    Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.

  192. 2018

    LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.

    FavorávelEstudo em AnimaisDiabetesCanabidiol Anormal (Abn-CBD)
  193. 2018

    Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents.

    FavorávelEstudo em AnimaisAVCCanabinoides Sintéticos AM-x
  194. 2018

    Medical Cannabis for Neuropathic Pain.

  195. 2018

    Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study

  196. 2018

    Neuroprotection by (Endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases

  197. 2018

    Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2.

    FavorávelEstudo em AnimaisDoença de AlzheimerDemênciaCanabinoides Sintéticos AM-x
  198. 2018

    Polyunsaturated fatty acids and endocannabinoids in health and disease

  199. 2018

    Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation

    FavorávelEnsaio ClínicoInflamaçãoFibroseEsclerose SistêmicaDelta-8-THC+1
  200. 2018

    Psychosis and synthetic cannabinoids

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  201. 2018

    Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization

  202. 2018

    Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  203. 2018

    Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists

    InconclusivoEstudo LaboratorialObesidadeSíndrome Metabólica
  204. 2018

    Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  205. 2018

    The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus.

    FavorávelEstudo em AnimaisVírus Sincicial RespiratórioCanabinoides Sintéticos AM-x
  206. 2018

    The role of cannabinoid signaling in acute and chronic kidney diseases

    FavorávelMetanáliseInsuficiência RenalNefropatia Diabética
  207. 2018

    The Therapeutic Potential of Cannabinoids in Dermatology

  208. 2018

    The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

  209. 2018

    Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.

    FavorávelMetanáliseEsclerose MúltiplaAnandamida (AEA)Tetraidrocanabinol (THC)+9
  210. 2018

    Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain

  211. 2017

    A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery

    InconclusivoEnsaio ClínicoDorNáusea e VômitoDor — AgudaTHC Farmacêutico+1
  212. 2017

    Acute effects of synthetic cannabinoids: Update 2015

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  213. 2017

    Acute Poisonings from Synthetic Cannabinoids — 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010–2015

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  214. 2017

    Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.

  215. 2017

    Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.

  216. 2017

    Cannabinoids and Pain: Sites and Mechanisms of Action.

  217. 2017

    Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

  218. 2017

    Cannabis, cannabinoids, and health

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  219. 2017

    Dermatological aspects of synthetic cannabinoid addiction

  220. 2017

    Effects of the cannabinoid CB 1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs

    InconclusivoEstudo em AnimaisZumbido
  221. 2017

    Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoEsclerose MúltiplaTetraidrocanabinol (THC)+1
  222. 2017

    Endocannabinoids: A Promising Impact for Traumatic Brain Injury

  223. 2017

    Focus on cannabinoids and synthetic cannabinoids

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  224. 2017

    Hepatotoxicity Associated to Synthetic Cannabinoids Use

    DesfavorávelMetanáliseIntoxicação por Cannabis SintéticaHepatotoxicidade
  225. 2017

    Ischemic stroke associated with the use of a synthetic cannabinoid (spice).

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  226. 2017

    Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.

  227. 2017

    Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling

    FavorávelEstudo em AnimaisObesidade
  228. 2017

    Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation

  229. 2017

    Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis.

    FavorávelEstudo LaboratorialEsclerose Múltipla
  230. 2017

    Role of cannabis in cardiovascular disorders.

    InconclusivoMetanáliseDoenças Cardiovasculares (DCV)AVC
  231. 2017

    Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  232. 2017

    Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  233. 2017

    Synthetic Cannabis Analogues and Suicidal Behavior: Case Report

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadePsicose+3
  234. 2017

    Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

  235. 2017

    The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  236. 2017

    The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.

  237. 2016

    A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes

  238. 2016

    Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.

  239. 2016

    Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies.

  240. 2016

    Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials

    FavorávelMetanálise ClínicaDorInsônia e Distúrbios do SonoArtriteTHC Farmacêutico+3
  241. 2016

    Endocannabinoid System: A Multi-Facet Therapeutic Target.

  242. 2016

    Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

  243. 2016

    Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  244. 2016

    Repeated Thrombosis After Synthetic Cannabinoid Use.

  245. 2016

    Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report

    DesfavorávelMetanáliseIntoxicação por Cannabis SintéticaDoença Falciforme
  246. 2016

    Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  247. 2016

    Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure

  248. 2016

    The Effect Of Cannabinoids On Dinitrofluorobenzene-induced Experimental Asthma In Mice

    FavorávelEstudo em AnimaisAsma
  249. 2016

    The endocannabinoid system and bone.

    FavorávelMetanáliseOsteoporoseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  250. 2016

    The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism

    FavorávelEstudo em AnimaisObesidadeSíndrome Metabólica
  251. 2016

    The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation

    InconclusivoEstudo LaboratorialEndocanabinoide (não especificado)
  252. 2016

    Type-2 cannabinoid receptors in neurodegeneration

  253. 2015

    A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  254. 2015

    Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

    FavorávelEstudo LaboratorialHIV/AIDS2-Araquidonoilglicerol (2-AG)THC Farmacêutico+4
  255. 2015

    Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice

    FavorávelEstudo em AnimaisAVCCanabinoides Sintéticos AM-x
  256. 2015

    Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

  257. 2015

    Effects of Cannabinoids on T-cell Function and Resistance to Infection.

  258. 2015

    GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC

    DesfavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaTetraidrocanabinol (THC)
  259. 2015

    Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress

  260. 2015

    K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

  261. 2015

    Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — CrônicaDependência — OpioidesTHC Farmacêutico+4
  262. 2015

    The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  263. 2014

    "Spice"--synthetic cannabinoids with dangerous effects

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  264. 2014

    A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.

  265. 2014

    A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid

    DesfavorávelMetanáliseAVCIntoxicação por Cannabis Sintética
  266. 2014

    A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior

    FavorávelMetanáliseEndocanabinoide (não especificado)
  267. 2014

    A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  268. 2014

    Cannabinoid Signaling In Glioma Cells

  269. 2014

    Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system

  270. 2014

    Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)

  271. 2014

    Harnessing neuroendocrine controls of keratin expression: a new therapeutic strategy for skin diseases?

  272. 2014

    In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects

  273. 2014

    Ischemic stroke after use of the synthetic marijuana "spice"

  274. 2014

    Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs

  275. 2014

    Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011

    DesfavorávelMetanáliseDepressãoTentativa de SuicídioTHC Farmacêutico
  276. 2014

    Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  277. 2014

    Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome

  278. 2014

    Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports

    FavorávelMetanáliseAnsiedadeIntoxicação por Cannabis Sintética
  279. 2014

    Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints

    FavorávelEstudo em AnimaisDorInflamaçãoDor — AgudaCanabinoides Sintéticos AM-x
  280. 2014

    The endocannabinoid system and appetite: relevance for food reward

  281. 2014

    Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.

  282. 2013

    A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids

  283. 2013

    Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  284. 2013

    Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

  285. 2013

    AKI Associated with Synthetic Cannabinoids: A Case Series

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  286. 2013

    Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists

    FavorávelEstudo LaboratorialCâncerCâncer — Pâncreas
  287. 2013

    Critical Appraisal Of The Potential Use Of Cannabinoids In Cancer Management

  288. 2013

    Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicoseEsquizofreniaCanabinoides Sintéticos SR-x+3
  289. 2013

    Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine

    FavorávelEstudo em AnimaisEnxaquecaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  290. 2013

    Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut.

  291. 2013

    Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat

    FavorávelEstudo em AnimaisDorInflamaçãoEdemaCanabinoides Sintéticos SR-x
  292. 2013

    Synthetic cannabinoid overdose in a 20-year-old male US soldier

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  293. 2013

    Targeting the Endocannabinoid System to Treat Sepsis.

    FavorávelMetanáliseSepseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  294. 2013

    The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).

  295. 2013

    The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.

    InconclusivoMetanálise ClínicaHIV/AIDSEndocanabinoide (não especificado)THC Farmacêutico
  296. 2013

    The synthetic cannabinoid withdrawal syndrome

    DesfavorávelMetanálise
  297. 2012

    Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong

    DesfavorávelMetanáliseIntoxicação por Cannabis Sintética
  298. 2012

    Cannabis—A Valuable Drug That Deserves Better Treatment

  299. 2012

    CB(1) blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans

  300. 2012

    Does rimonabant independently affect free fatty acid and glucose metabolism?

  301. 2009

    Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers

    InconclusivoEnsaio Clínico Duplo-CegoDepressão
  302. 2002

    International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

    InconclusivoMetanáliseEndocanabinoide (não especificado)
  303. 1996

    Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands

    InconclusivoEstudo LaboratorialEndocanabinoide (não especificado)

Continue por aqui

Perguntas frequentes

Quantos estudos sobre canabinoide sintético (não especificado) estão indexados no acervo?
São 384 estudos, publicados entre 1981 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 196 · Estudo em Animais: 83 · Ensaio Clínico Duplo-Cego: 38 · Estudo Laboratorial: 33 · Ensaio Clínico: 20 · Metanálise Clínica: 14. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 216 favoráveis, 58 inconclusivos e 110 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Canabinoide Sintético (não especificado) — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/canabinoide/canabinoide-sintetico-nao-especificado/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Canabinoide Sintético (não especificado) — estudos científicos sobre cannabis. https://cannabisindica.com.br/canabinoide/canabinoide-sintetico-nao-especificado/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.